BTCY

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/10/2016
Contact Info
  • 75 International Blvd
  • Suite 300
  • Toronto, ONT M9W 6L9
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001630113
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2012
Employees 1 a/o Nov 10, 2015
Company Officers/Contacts
Waqaas Al-Siddiq President, CEO
Tom Nelson Advisory Director
John Rother Advisory Director
Bernard Rice Advisory Director
Danny Sands Advisory Director
Nayyar Razvi Advisory Director
David Liepert Advisory Director
Company Directors
Waqaas Al-Siddiq Chairman
Norman Betts
Dave Rosa
Company Notes
  • Formerly=MetaSolutions, Inc. until 2-2016
Service Providers
Accounting/Auditing Firm
SRCO Professional Corporation, Charted Accountant
15 Wertheim Court, Suit 409
Richmond Hill, ONT, L4B 3H7
Canada

Legal Counsel
Ruskin Moscou Faltischek, PC
1425 RXR Plaza
East Tower, 15th Floor
Uniondale, NY, 11556
United States

Investor Relations Firm
Liolios Group, Inc.
20371 Irvine Ave
Suite A-100
Newport Beach, CA, 92660
United States

BTCY Security Details
Share Structure
Market Value1 $42,828,972 a/o Dec 05, 2016
Authorized Shares 125,000,000 a/o Feb 05, 2016
Outstanding Shares 17,131,589 a/o Nov 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,500,000 a/o Aug 09, 2016
Par Value 0.001
Shareholders
Shareholders of Record 1,276 a/o Aug 09, 2016
Short Selling Data
Short Interest 2,486 (-22.87%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security